2.05 USD
+1.61 (+368.57%)
1.55 USD
-0.5 (-24.39%)
ChartMill assigns a Buy % Consensus number of 43% to LPTX. The Buy consensus is the weighted average rating of the current analysts ratings.
LPTX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about LPTX.
In the previous month the buy percentage consensus was at a similar level.
LPTX was analyzed by 6 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-27 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-01-29 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-01-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-28 | Rodman & Renshaw | Initiate | Buy |
| 2024-05-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-19 | Baird | Maintains | Outperform -> Outperform |
| 2024-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-20 | Mizuho | Maintains | Buy -> Buy |
| 2023-11-14 | Raymond James | Maintains | Outperform -> Outperform |
| 2023-08-15 | Baird | Maintains | Outperform -> Outperform |
| 2023-08-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-13 | Raymond James | Maintains | Outperform -> Outperform |
| 2023-06-23 | Raymond James | Maintains | Outperform -> Outperform |
| 2023-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-13 | Mizuho | Reiterate | Buy |
| 2023-03-27 | Raymond James | Maintains | Outperform |
| 2023-03-27 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-17 | Mizuho | Maintains | Buy |
| 2023-01-27 | Mizuho | Maintains | Buy |
| 2023-01-18 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-11 | Raymond James | Maintains | Outperform |
| 2022-08-15 | Raymond James | Maintains | Outperform |
| 2022-07-13 | Raymond James | Maintains | Outperform |
| 2021-10-04 | Mizuho | Initiate | Buy |
| 2021-09-14 | Raymond James | Maintains | Outperform |
| 2021-03-02 | Raymond James | Maintains | Outperform |
LEAP THERAPEUTICS INC / LPTX FAQ
Can you provide the consensus rating for LEAP THERAPEUTICS INC stock?
The consensus rating for LEAP THERAPEUTICS INC (LPTX) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.